Review



human bone marrow stromal cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    ATCC human bone marrow stromal cells
    Human Bone Marrow Stromal Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 417 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow stromal cells/product/ATCC
    Average 97 stars, based on 417 article reviews
    human bone marrow stromal cells - by Bioz Stars, 2026-04
    97/100 stars

    Images



    Similar Products

    97
    ATCC human bone marrow stromal cells
    Human Bone Marrow Stromal Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow stromal cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    human bone marrow stromal cells - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    94
    CLS Cell Lines Service GmbH human bone marrow stromal cells mscs
    Human Bone Marrow Stromal Cells Mscs, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow stromal cells mscs/product/CLS Cell Lines Service GmbH
    Average 94 stars, based on 1 article reviews
    human bone marrow stromal cells mscs - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    97
    ATCC human normal bone marrow stromal cell line hs 5
    Human Normal Bone Marrow Stromal Cell Line Hs 5, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human normal bone marrow stromal cell line hs 5/product/ATCC
    Average 97 stars, based on 1 article reviews
    human normal bone marrow stromal cell line hs 5 - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    97
    ATCC human bone marrow stromal cell line hs 5
    Human Bone Marrow Stromal Cell Line Hs 5, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow stromal cell line hs 5/product/ATCC
    Average 97 stars, based on 1 article reviews
    human bone marrow stromal cell line hs 5 - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    96
    ATCC murine bone marrow stromal cells
    Murine Bone Marrow Stromal Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine bone marrow stromal cells/product/ATCC
    Average 96 stars, based on 1 article reviews
    murine bone marrow stromal cells - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    97
    ATCC human bone marrow stromal cells hs 5
    Human Bone Marrow Stromal Cells Hs 5, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human bone marrow stromal cells hs 5/product/ATCC
    Average 97 stars, based on 1 article reviews
    human bone marrow stromal cells hs 5 - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    97
    ATCC stromal bone marrow cells
    A Tumor cell proliferation was monitored by longitudinal full body bioluminescence imaging. Representative images of three animals per group. Mouse IDs are given for each animal to allow for allocation of individual animals in ( B , C ). B Bioluminescence signals from dorsal and ventral images were quantified. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Imaging was discontinued once technical signal saturation was achieved. Kolmogorov–Smirnov test for each time point. * p < 0.05. C Quantification of GFP + tumor cell frequency in peripheral blood using flow cytometry. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Kolmogorov–Smirnov test for each time point. * p < 0.05; ** p < 0.01. D Kaplan–Meier survival analysis. 6–8 animals per group, Log-rank test. ** p < 0.01. E Relative tumor cell doubling times were calculated based on bioluminescence data ( B ; early proliferation) and peripheral blood flow cytometry values ( C ; late proliferation) and compared to time-matched vehicle cohorts. Mean ± SD of 5–8 animals per group, multiple data sets per animal during the exponential growth phase. Kolmogorov–Smirnov test. * p < 0.05; ** p < 0.01; *** p < 0.001. F Determination of blast frequency in blood, <t>bone</t> <t>marrow</t> and spleen by flow cytometry when the mice reached humane endpoints (30% blasts in blood or weak performance status). Mean ± SD of 4-6 animals per group. Welch’s t test. G Isolated VEN-resistant bone marrow <t>cells</t> were spun onto microscopic slides and Pappenheim stained. Representative images of 5–8 mice per group, ×100 magnification.
    Stromal Bone Marrow Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stromal bone marrow cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    stromal bone marrow cells - by Bioz Stars, 2026-04
    97/100 stars
      Buy from Supplier

    99
    ATCC bone marrow stromal cells bmscs
    A Tumor cell proliferation was monitored by longitudinal full body bioluminescence imaging. Representative images of three animals per group. Mouse IDs are given for each animal to allow for allocation of individual animals in ( B , C ). B Bioluminescence signals from dorsal and ventral images were quantified. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Imaging was discontinued once technical signal saturation was achieved. Kolmogorov–Smirnov test for each time point. * p < 0.05. C Quantification of GFP + tumor cell frequency in peripheral blood using flow cytometry. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Kolmogorov–Smirnov test for each time point. * p < 0.05; ** p < 0.01. D Kaplan–Meier survival analysis. 6–8 animals per group, Log-rank test. ** p < 0.01. E Relative tumor cell doubling times were calculated based on bioluminescence data ( B ; early proliferation) and peripheral blood flow cytometry values ( C ; late proliferation) and compared to time-matched vehicle cohorts. Mean ± SD of 5–8 animals per group, multiple data sets per animal during the exponential growth phase. Kolmogorov–Smirnov test. * p < 0.05; ** p < 0.01; *** p < 0.001. F Determination of blast frequency in blood, <t>bone</t> <t>marrow</t> and spleen by flow cytometry when the mice reached humane endpoints (30% blasts in blood or weak performance status). Mean ± SD of 4-6 animals per group. Welch’s t test. G Isolated VEN-resistant bone marrow <t>cells</t> were spun onto microscopic slides and Pappenheim stained. Representative images of 5–8 mice per group, ×100 magnification.
    Bone Marrow Stromal Cells Bmscs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bone marrow stromal cells bmscs/product/ATCC
    Average 99 stars, based on 1 article reviews
    bone marrow stromal cells bmscs - by Bioz Stars, 2026-04
    99/100 stars
      Buy from Supplier

    Image Search Results


    A Tumor cell proliferation was monitored by longitudinal full body bioluminescence imaging. Representative images of three animals per group. Mouse IDs are given for each animal to allow for allocation of individual animals in ( B , C ). B Bioluminescence signals from dorsal and ventral images were quantified. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Imaging was discontinued once technical signal saturation was achieved. Kolmogorov–Smirnov test for each time point. * p < 0.05. C Quantification of GFP + tumor cell frequency in peripheral blood using flow cytometry. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Kolmogorov–Smirnov test for each time point. * p < 0.05; ** p < 0.01. D Kaplan–Meier survival analysis. 6–8 animals per group, Log-rank test. ** p < 0.01. E Relative tumor cell doubling times were calculated based on bioluminescence data ( B ; early proliferation) and peripheral blood flow cytometry values ( C ; late proliferation) and compared to time-matched vehicle cohorts. Mean ± SD of 5–8 animals per group, multiple data sets per animal during the exponential growth phase. Kolmogorov–Smirnov test. * p < 0.05; ** p < 0.01; *** p < 0.001. F Determination of blast frequency in blood, bone marrow and spleen by flow cytometry when the mice reached humane endpoints (30% blasts in blood or weak performance status). Mean ± SD of 4-6 animals per group. Welch’s t test. G Isolated VEN-resistant bone marrow cells were spun onto microscopic slides and Pappenheim stained. Representative images of 5–8 mice per group, ×100 magnification.

    Journal: NPJ Precision Oncology

    Article Title: Venetoclax resistance in preclinical KMT2A-rearranged acute lymphoblastic leukemia models is characterized by high inter- and intra-model heterogeneity

    doi: 10.1038/s41698-025-01249-1

    Figure Lengend Snippet: A Tumor cell proliferation was monitored by longitudinal full body bioluminescence imaging. Representative images of three animals per group. Mouse IDs are given for each animal to allow for allocation of individual animals in ( B , C ). B Bioluminescence signals from dorsal and ventral images were quantified. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Imaging was discontinued once technical signal saturation was achieved. Kolmogorov–Smirnov test for each time point. * p < 0.05. C Quantification of GFP + tumor cell frequency in peripheral blood using flow cytometry. 5–8 animals per group, each line represents an individual animal. Mice displayed in ( A ) are marked with the respective mouse ID. Kolmogorov–Smirnov test for each time point. * p < 0.05; ** p < 0.01. D Kaplan–Meier survival analysis. 6–8 animals per group, Log-rank test. ** p < 0.01. E Relative tumor cell doubling times were calculated based on bioluminescence data ( B ; early proliferation) and peripheral blood flow cytometry values ( C ; late proliferation) and compared to time-matched vehicle cohorts. Mean ± SD of 5–8 animals per group, multiple data sets per animal during the exponential growth phase. Kolmogorov–Smirnov test. * p < 0.05; ** p < 0.01; *** p < 0.001. F Determination of blast frequency in blood, bone marrow and spleen by flow cytometry when the mice reached humane endpoints (30% blasts in blood or weak performance status). Mean ± SD of 4-6 animals per group. Welch’s t test. G Isolated VEN-resistant bone marrow cells were spun onto microscopic slides and Pappenheim stained. Representative images of 5–8 mice per group, ×100 magnification.

    Article Snippet: SEM or RS4;11 cells were cultivated alone or cocultured with human stromal bone marrow cells (HS-5 cell line, ATCC, Manassas, VI, USA) and incubated with DMSO (control) or VEN for 72 h. Absolute cell counts were assessed by trypan blue staining and subsequent microscopic quantification.

    Techniques: Imaging, Flow Cytometry, Isolation, Staining

    A Quantification of CD45 + /CD19 + tumor cell frequency in peripheral blood using flow cytometry. 1–3 animals per group, each line represents an individual animal. B Kaplan–Meier survival analysis. All five PDX models were summarized. 15 animals per group, Log-rank test. * p < 0.05. C Tumor cell doubling times were calculated based on peripheral blood flow cytometry values ( A ). Mean ± SD of 1–3 animals per group, multiple data sets per animal during exponential growth phase. Unpaired t test. D Tumor cell doubling times summarized for all five PDX models. Mean ± SD of 1–3 animals per group, multiple data sets per animal during exponential growth phase. Kolmogorov–Smirnov test. E Determination of blast frequency in blood, bone marrow and spleen by flow cytometry when the mice reached humane endpoints (30% blasts in blood or weak performance status) or study endpoint (120 days post tumor cell injection). Mean ± SD of 1–3 animals per group. Kolmogorov–Smirnov test. F Tumor cell frequency in blood, bone marrow and spleen at experiment termination, summary of all five PDX models. Mean ± SD of 1–3 animals per group. No statistical assessment due to animals lacking VEN resistance. G Isolated VEN-resistant bone marrow cells were spun onto microscopic slides and Pappenheim stained. Representative images of 1–3 mice per group, 100x magnification. No statistic assessment of data from patients #0054 and #0152 derived models due to animals VEN-treated animals lacking resistance establishment.

    Journal: NPJ Precision Oncology

    Article Title: Venetoclax resistance in preclinical KMT2A-rearranged acute lymphoblastic leukemia models is characterized by high inter- and intra-model heterogeneity

    doi: 10.1038/s41698-025-01249-1

    Figure Lengend Snippet: A Quantification of CD45 + /CD19 + tumor cell frequency in peripheral blood using flow cytometry. 1–3 animals per group, each line represents an individual animal. B Kaplan–Meier survival analysis. All five PDX models were summarized. 15 animals per group, Log-rank test. * p < 0.05. C Tumor cell doubling times were calculated based on peripheral blood flow cytometry values ( A ). Mean ± SD of 1–3 animals per group, multiple data sets per animal during exponential growth phase. Unpaired t test. D Tumor cell doubling times summarized for all five PDX models. Mean ± SD of 1–3 animals per group, multiple data sets per animal during exponential growth phase. Kolmogorov–Smirnov test. E Determination of blast frequency in blood, bone marrow and spleen by flow cytometry when the mice reached humane endpoints (30% blasts in blood or weak performance status) or study endpoint (120 days post tumor cell injection). Mean ± SD of 1–3 animals per group. Kolmogorov–Smirnov test. F Tumor cell frequency in blood, bone marrow and spleen at experiment termination, summary of all five PDX models. Mean ± SD of 1–3 animals per group. No statistical assessment due to animals lacking VEN resistance. G Isolated VEN-resistant bone marrow cells were spun onto microscopic slides and Pappenheim stained. Representative images of 1–3 mice per group, 100x magnification. No statistic assessment of data from patients #0054 and #0152 derived models due to animals VEN-treated animals lacking resistance establishment.

    Article Snippet: SEM or RS4;11 cells were cultivated alone or cocultured with human stromal bone marrow cells (HS-5 cell line, ATCC, Manassas, VI, USA) and incubated with DMSO (control) or VEN for 72 h. Absolute cell counts were assessed by trypan blue staining and subsequent microscopic quantification.

    Techniques: Flow Cytometry, Injection, Isolation, Staining, Derivative Assay